Research Library — Peptide Longevity Q&A — Page 14 | Reta Compare

640 research articles in Peptide Longevity Q&A. Page 14 of 26.

Articles

• How does IGF-1 LR3 affect oxidative stress and aging mechanisms?
• Can IGF-1 LR3 promote autophagy and cellular cleanup in acromegaly?
• How does IGF-1 LR3 influence lifespan extension in aging models?
• Can IGF-1 LR3 influence cell proliferation and DNA damage in aging tissues?
• How does Ipamorelin affect muscle preservation in aging models?
• Can Ipamorelin stimulate appetite and muscle mass in aging individuals?
• Can Ipamorelin reduce age-related muscle loss (sarcopenia)?
• Can Ipamorelin reduce neuroinflammation and improve brain health in aging?
• Can Ipamorelin improve lean body mass in cancer cachexia?
• Can Ipamorelin reduce age-related muscle loss in cancer patients?
• Can Ipamorelin prevent muscle loss in cancer cachexia models?
• Can Ipamorelin support mitochondrial function in aging cardiovascular tissue?
• Can Ipamorelin help manage cancer cachexia in aging patients?
• Can Ipamorelin improve muscle mass in aging individuals?
• How does KPV affect hepatic lipid accumulation and oxidative stress?
• Can KPV protect against skin damage from environmental pollutants?
• Can KPV and rapamycin reduce vascular calcification in aging populations?
• Can KPV improve intestinal barrier integrity in inflammatory bowel disease?
• Does KPV reduce inflammaging in older adults?
• Does Liraglutide reduce inflammaging in diabetic periodontitis?
• Can Liraglutide promote autophagy and cellular cleanup in arthritis?
• How does Liraglutide enhance tissue regeneration in aging bone?
• Can Liraglutide prevent metabolic decline in postmenopausal models?
• How does Liraglutide promote osteogenic differentiation in dental pulp stem cells?
• How does Liraglutide affect metabolic aging and insulin sensitivity?